Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells

Abstract Cutaneous and Head and Neck squamous cell carcinoma (CSCC, HNSCC) are among the most prevalent cancers. Both types of cancer can be treated with photodynamic therapy (PDT) by using the photosensitizer Temoporfin in HNSCC and the prodrug methyl-aminolevulinate (MAL) in CSCC. However, PDT is...

Full description

Bibliographic Details
Main Authors: J. Nicolás-Morala, M. Alonso-Juarranz, A. Barahona, S. Terrén, S. Cabezas, F. Falahat, Y. Gilaberte, S. Gonzalez, A. Juarranz, M. Mascaraque
Format: Article
Language:English
Published: Nature Portfolio 2024-03-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-024-57624-8
_version_ 1827301159617953792
author J. Nicolás-Morala
M. Alonso-Juarranz
A. Barahona
S. Terrén
S. Cabezas
F. Falahat
Y. Gilaberte
S. Gonzalez
A. Juarranz
M. Mascaraque
author_facet J. Nicolás-Morala
M. Alonso-Juarranz
A. Barahona
S. Terrén
S. Cabezas
F. Falahat
Y. Gilaberte
S. Gonzalez
A. Juarranz
M. Mascaraque
author_sort J. Nicolás-Morala
collection DOAJ
description Abstract Cutaneous and Head and Neck squamous cell carcinoma (CSCC, HNSCC) are among the most prevalent cancers. Both types of cancer can be treated with photodynamic therapy (PDT) by using the photosensitizer Temoporfin in HNSCC and the prodrug methyl-aminolevulinate (MAL) in CSCC. However, PDT is not always effective. Therefore, it is mandatory to correctly approach the therapy according to the characteristics of the tumour cells. For this reason, we have used cell lines of CSCC (A431 and SCC13) and HNSCC (HN5 and SCC9). The results obtained indicated that the better response to MAL-PDT was related to its localization in the plasma membrane (A431 and HN5 cells). However, with Temoporfin all cell lines showed lysosome localization, even the most sensitive ones (HN5). The expression of mesenchymal markers and migratory capacity was greater in HNSCC lines compared to CSCC, but no correlation with PDT response was observed. The translocation to the nucleus of β-catenin and GSK3β and the activation of NF-κβ is related to the poor response to PDT in the HNSCC lines. Therefore, we propose that intracellular localization of GSK3β could be a good marker of response to PDT in HNSCC. Although the molecular mechanism of response to PDT needs further elucidation, this work shows that the most MAL-resistant line of CSCC is more sensitive to Temoporfin.
first_indexed 2024-04-24T16:18:20Z
format Article
id doaj.art-1877c44cbf3449a193a7dab5cd6311f3
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-24T16:18:20Z
publishDate 2024-03-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-1877c44cbf3449a193a7dab5cd6311f32024-03-31T11:17:33ZengNature PortfolioScientific Reports2045-23222024-03-0114111410.1038/s41598-024-57624-8Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cellsJ. Nicolás-Morala0M. Alonso-Juarranz1A. Barahona2S. Terrén3S. Cabezas4F. Falahat5Y. Gilaberte6S. Gonzalez7A. Juarranz8M. Mascaraque9Department of Biology, Universidad Autónoma de MadridOral and Maxillofacial Surgery Service, Hospital Clínico San CarlosDepartment of Biology, Universidad Autónoma de MadridDepartment of Biology, Universidad Autónoma de MadridOncology Service, Hospital Clínico San CarlosOral and Maxillofacial Surgery Service, Hospital Clínico San CarlosDepartment of Dermatology, Miguel Servet University Hospital, Instituto Investigación Sanitaria (IIS)Department of Experimental Dermatology and Skin Biology, Instituto Ramón y Cajal de Investigación Sanitaria, IRYCISDepartment of Biology, Universidad Autónoma de MadridDepartment of Biology, Universidad Autónoma de MadridAbstract Cutaneous and Head and Neck squamous cell carcinoma (CSCC, HNSCC) are among the most prevalent cancers. Both types of cancer can be treated with photodynamic therapy (PDT) by using the photosensitizer Temoporfin in HNSCC and the prodrug methyl-aminolevulinate (MAL) in CSCC. However, PDT is not always effective. Therefore, it is mandatory to correctly approach the therapy according to the characteristics of the tumour cells. For this reason, we have used cell lines of CSCC (A431 and SCC13) and HNSCC (HN5 and SCC9). The results obtained indicated that the better response to MAL-PDT was related to its localization in the plasma membrane (A431 and HN5 cells). However, with Temoporfin all cell lines showed lysosome localization, even the most sensitive ones (HN5). The expression of mesenchymal markers and migratory capacity was greater in HNSCC lines compared to CSCC, but no correlation with PDT response was observed. The translocation to the nucleus of β-catenin and GSK3β and the activation of NF-κβ is related to the poor response to PDT in the HNSCC lines. Therefore, we propose that intracellular localization of GSK3β could be a good marker of response to PDT in HNSCC. Although the molecular mechanism of response to PDT needs further elucidation, this work shows that the most MAL-resistant line of CSCC is more sensitive to Temoporfin.https://doi.org/10.1038/s41598-024-57624-8
spellingShingle J. Nicolás-Morala
M. Alonso-Juarranz
A. Barahona
S. Terrén
S. Cabezas
F. Falahat
Y. Gilaberte
S. Gonzalez
A. Juarranz
M. Mascaraque
Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
Scientific Reports
title Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
title_full Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
title_fullStr Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
title_full_unstemmed Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
title_short Comparative response to PDT with methyl-aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
title_sort comparative response to pdt with methyl aminolevulinate and temoporfin in cutaneous and oral squamous cell carcinoma cells
url https://doi.org/10.1038/s41598-024-57624-8
work_keys_str_mv AT jnicolasmorala comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT malonsojuarranz comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT abarahona comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT sterren comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT scabezas comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT ffalahat comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT ygilaberte comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT sgonzalez comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT ajuarranz comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells
AT mmascaraque comparativeresponsetopdtwithmethylaminolevulinateandtemoporfinincutaneousandoralsquamouscellcarcinomacells